首页> 外文期刊>Agriculture and Biology Journal of North America >Acute and sub-chronic toxicity studies of the ethanol extract of the leaves of Sphenocentrum jollyanum (Menispermaceae)
【24h】

Acute and sub-chronic toxicity studies of the ethanol extract of the leaves of Sphenocentrum jollyanum (Menispermaceae)

机译:竹叶仙客来(Menispermaceae)叶片乙醇提取物的急性和亚慢性毒性研究

获取原文
       

摘要

The acute toxicity study of the leaves of Sphenocentrum jollyanum (SJ) showed no toxicity whenadministered up to 11g/kg body weight orally while intra-peritoneal (IP) administration produceddose dependent mortality with median acute toxicity (LD50) of 1445.4 mg/kg. In sub-chronic study,the extract administered for a period of 120 days showed no mortality or morbidity. There wassignificant weight gain in both treated and control groups while gross examination of internalorgans revealed no detectable inflammation. The blood glucose and total cholesterol levelsdemonstrated dose dependent decrease while high density lipoprotein cholesterol (HDLcholesterol)increased with dose. In the liver function test, there were no significant (p>0.05)changes in alanine amino transferase (ALT) and aspertate amino transferase (AST) in the extracttreated animals. The renal function profile, serum creatinine and urea levels were not significantlyaltered compared to the control. In haematological evaluation, significant increase (p<0.05) in redblood cells (RBC), packed cell volume (PCV) and haemoglobin (Hb) were observed in the treatedanimals compared to the control while mean corpuscular (MCV), mean corpuscular haemoglobin(MCH), mean corpuscular haemoglobin concentration (MCHC) and white blood cells (WBC)showed no significant changes. The result therefore suggests that the leaves extract waspotentially safe for consumption orally even at chronic administration.
机译:竹叶仙竹(SJ)叶片的急性毒性研究显示,口服最高至11g / kg体重时无毒性,而腹膜内(IP)给药产生剂量依赖性死亡率,中位急性毒性(LD50)为1445.4 mg / kg。在亚慢性研究中,给予提取物120天的时间未显示出死亡率或发病率。在治疗组和对照组中体重都有显着增加,而对内脏器官的总体检查显示没有可检测到的炎症。血糖和总胆固醇水平显示剂量依赖性降低,而高密度脂蛋白胆固醇(HDL胆固醇)随剂量升高。在肝功能测试中,在提取的动物中,丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)没有显着(p> 0.05)变化。与对照组相比,肾脏功能状况,血清肌酐和尿素水平没有明显改变。在血液学评估中,与对照组相比,治疗动物的血红细胞(RBC),堆积细胞体积(PCV)和血红蛋白(Hb)显着增加(p <0.05),而平均红细胞(MCV),平均红细胞血红蛋白(MCH) ),平均红细胞血红蛋白浓度(MCHC)和白细胞(WBC)均无明显变化。因此,结果表明即使在长期给药下,叶提取物口服食用也可能安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号